Protein Arginine Methyltransferase 1 mediates Renal Fibroblast Activation and fibrogenesis through activation of Smad3 signaling.
暂无分享,去创建一个
[1] A. Burlingame,et al. Arginine methylation of SMAD7 by PRMT1 in TGF-β–induced epithelial–mesenchymal transition and epithelial stem-cell generation , 2018, The Journal of Biological Chemistry.
[2] N. Sheerin,et al. The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3 , 2018, Journal of Cell Science.
[3] S. Zhuang,et al. Src family kinases in chronic kidney disease. , 2017, American journal of physiology. Renal physiology.
[4] B. Kessler,et al. Protein arginine methylation: a prominent modification and its demethylation , 2017, Cellular and Molecular Life Sciences.
[5] Xin-Hua Feng,et al. Posttranslational Regulation of Smads. , 2016, Cold Spring Harbor perspectives in biology.
[6] R. San Martín,et al. The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis. , 2016, Cytokine.
[7] A. Józkowicz,et al. TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation , 2016, Mediators of inflammation.
[8] S. Zhuang,et al. Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression. , 2016, Journal of the American Society of Nephrology : JASN.
[9] G. Panayotou,et al. SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis , 2016, Cell reports.
[10] Xiao-ming Meng,et al. TGF-β: the master regulator of fibrosis , 2016, Nature Reviews Nephrology.
[11] Mary E. Choi,et al. TGF-β signaling in the kidney: profibrotic and protective effects. , 2016, American journal of physiology. Renal physiology.
[12] Jun Lu,et al. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1 , 2016, Scientific Reports.
[13] R. Schermuly,et al. Elevated protein arginine methyltransferase 1 expression regulates fibroblast motility in pulmonary fibrosis. , 2015, Biochimica et biophysica acta.
[14] S. Weiss,et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease , 2015, Nature Medicine.
[15] B. Cha,et al. Protein Arginine Methyltransferase 1 Methylates Smurf2 , 2015, Molecules and cells.
[16] Guoying Wu,et al. Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy , 2015, Toxicology mechanisms and methods.
[17] Shemin Lu,et al. PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary Inflammation , 2015, The Journal of Immunology.
[18] Melissa R. Pergande,et al. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer* , 2015, The Journal of Biological Chemistry.
[19] J. Weinberg,et al. Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression. , 2015, Journal of the American Society of Nephrology : JASN.
[20] S. Zhuang,et al. EGFR signaling in renal fibrosis , 2014, Kidney international supplements.
[21] Tao Lu,et al. Protein arginine methylation of non-histone proteins and its role in diseases , 2013, Cell cycle.
[22] A. Burlingame,et al. Arginine Methylation Initiates BMP-Induced Smad Signaling. , 2013, Molecular cell.
[23] M. Bedford,et al. Protein arginine methyltransferases and cancer , 2012, Nature Reviews Cancer.
[24] K. Preissner,et al. Protein Arginine Methyltransferases (PRMTs): Promising Targets for the Treatment of Pulmonary Disorders , 2012, International journal of molecular sciences.
[25] H. Lan,et al. TGF-β/Smad signaling in kidney disease. , 2012, Seminars in nephrology.
[26] E. Schwedhelm,et al. The role of asymmetric and symmetric dimethylarginines in renal disease , 2011, Nature Reviews Nephrology.
[27] Xun Xu,et al. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy. , 2009, Experimental eye research.
[28] S. Zhuang,et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. , 2009, American journal of physiology. Renal physiology.
[29] H. Iwasaki. Impaired PRMT1 activity in the liver and pancreas of type 2 diabetic Goto-Kakizaki rats. , 2009, Life sciences.
[30] M. T. Grande,et al. Fibroblast activation and myofibroblast generation in obstructive nephropathy , 2009, Nature Reviews Nephrology.
[31] Frank Herrmann,et al. Nucleo‐cytoplasmic shuttling of protein arginine methyltransferase 1 (PRMT1) requires enzymatic activity , 2009, Genes to cells : devoted to molecular & cellular mechanisms.
[32] U. Hellman,et al. Methylation of Smad6 by protein arginine N‐methyltransferase 1 , 2006, FEBS letters.
[33] Youhua Liu,et al. Renal fibrosis: new insights into the pathogenesis and therapeutics. , 2006, Kidney international.
[34] S. Tyagi,et al. Mechanisms of homocysteine-induced oxidative stress. , 2005, American journal of physiology. Heart and circulatory physiology.
[35] H. Ruley,et al. Arginine N-Methyltransferase 1 Is Required for Early Postimplantation Mouse Development, but Cells Deficient in the Enzyme Are Viable , 2000, Molecular and Cellular Biology.
[36] M. Cleman,et al. Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease? , 2013, Current topics in medicinal chemistry.
[37] C. D. Krause,et al. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. , 2007, Pharmacology & therapeutics.
[38] C. Allis,et al. Histone arginine methylation and its dynamic regulation. , 2006, Frontiers in bioscience : a journal and virtual library.